On 2025-05-15, Aptevo Therapeutics Inc. (APVO) announced earnings per share of $-87.80 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-84.20.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-83.20 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-15 | 2025-03-31 | $-84.20 | $-87.80 |
| 2024-11-07 | 2024-09-30 | $-413.04 | $-347.83 |
| 2024-08-08 | 2024-06-30 | $-1398.55 | $-1210.14 |
| 2024-05-08 | 2024-03-31 | $-10217.39 | $-7210.14 |
| 2023-11-14 | 2023-09-30 | $-22984.10 | $-15961.18 |
| 2023-08-10 | 2023-06-30 | $-35753.05 | $-39264.51 |
| 2023-05-11 | 2023-03-31 | $-37987.61 | $8299.81 |
| 2022-11-10 | 2022-09-30 | $-52352.67 | $-48841.21 |
| 2022-08-11 | 2022-06-30 | $-42456.74 | $-59375.59 |
| 2022-05-12 | 2022-03-31 | $-36710.71 | $-50756.56 |
| 2021-11-12 | 2021-09-30 | $-47245.10 | $-46287.43 |
| 2021-08-12 | 2021-06-30 | $-62248.61 | $-56821.80 |
| 2021-05-11 | 2021-03-31 | $-51714.23 | $-55544.91 |
| 2020-11-10 | 2020-09-30 | $-65440.84 | $-68633.08 |
| 2020-08-14 | 2020-06-30 | $-72463.77 | $-67036.96 |
| 2020-05-13 | 2020-03-31 | $-81402.02 | $-77252.12 |
| 2019-11-07 | 2019-09-30 | $-107302.05 | $-102831.14 |
| 2019-08-09 | 2019-06-30 | $-169894.92 | $-134127.58 |
| 2019-05-09 | 2019-03-31 | $-214604.11 | $-196720.44 |
| 2018-11-14 | 2018-09-30 | $-263784.22 | $-250371.45 |
| 2018-08-09 | 2018-06-30 | $-290609.72 | $-259313.30 |
| 2018-05-10 | 2018-03-31 | $-250371.45 | $-281667.88 |
| 2017-11-09 | 2017-09-30 | $1005956.75 | $62592.86 |
| 2017-08-10 | 2017-06-30 | -- | $-236958.69 |
| 2017-05-12 | 2017-03-31 | $-317435.22 | $-214604.11 |
| 2017-03-31 | 2016-12-31 | -- | $4470.92 |
| 2016-11-14 | 2016-09-30 | $-286138.81 | $-357673.53 |
| 2016-08-25 | 2016-06-30 | -- | $-281667.88 |